CSafe Global has created the role of vice president of innovation – passive systems for Emilio Frattaruolo.
He has over a decade of experience with previous roles in engineering and operational leadership for both pharmaceutical manufacturers and cold chain service providers.
Frattaruolo will lead growth of CSafe’s passive product line, developing and maintaining the product roadmap and aligning the business to meet pharmaceutical cold chain shipment needs.
He will drive R&D initiatives for product innovation to support long-term global expansion, and also be responsible for expanding CSafe’s Cell and Gene Therapy market.
Patrick Schafer, CEO of CSafe Global says: “I am pleased to welcome Emilio Frattaruolo to the CSafe Global team. He brings a multitude of engineering and operational management experience to our leadership team. His deep understanding of the clinical and commercial cold chain distribution process will be a great asset to CSafe.”
Frattaruolo says: “The team at CSafe has developed best-in-class solutions for the ever-evolving and increasingly demanding requirements that today’s global supply chain present to our customers. We are highly motivated to ensure our clients are able to distribute their life saving therapies to an ever-expanding global patient population.”
